Vitamin B12 is a well-known micronutrient that has long been acknowledged for its essential role in maintaining nerve function, supporting red blood cell production, and facilitating DNA synthesis, all vital processes for overall health. Researchers led by Dr. Manuel Serrano at IRB Barcelona have now revealed that vitamin B12 also plays a pivotal role in cellular reprogramming and tissue regeneration.

Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK 11/16/2023

Novo Takes Aim at Lilly’s Zepbound in Head-to-Head Trial Versus Wegovy Combo 11/16/2023

Astellas Sees Path Forward for Gene Therapy Despite Four Patient Deaths 11/16/2023

Artificial Intelligence, Part 1: Bias, Access, ROI, Potential Success and Failure 11/16/2023

CorMedix Wins FDA Approval for Antimicrobial Drug Combo After Two Rejections 11/16/2023

BMS Drug Augtyro Gets FDA Approval to Treat ROS1-Positive NSCLC 11/16/2023

Career Coach: Does LinkedIn’s 'Open to Work' Banner Make Me Look Desperate? 11/16/2023

New Initiatives Pump Money into Cell and Gene Therapy Development in New York 11/16/2023

A nationwide programme to reduce the risk of developing diabetes in the UK is proven beyond reasonable doubt to work, a new study reveals.

The positive effects observed in the NHS Diabetes Prevention Programme - the largest such project in the world helping people across the UK to lose weight and control their blood sugar levels - may have relevance globally for tackling the diabetes epidemic.

Gilead’s Kite Expands Arcellx Pact with $285M Equity Investment, Upfront Cash 11/15/2023

Alkermes Spins Off Oncology Business with $275M to Focus on Neuroscience 11/15/2023

Pfizer to Cut 500 Jobs at UK Site as Part of $3.5B Cost-Savings Campaign 11/15/2023

Zepbound vs Wegovy: A Two-Horse Race 11/15/2023

Israeli Biopharma Execs Vow Resilience, Anticipate Long-Term Fallout from Gaza War 11/15/2023

ZZ Biotech Hit with Data Manipulation Allegations Regarding Stroke Trial 11/15/2023

Bayer’s Lymphoma Treatment Aliqopa to be Pulled from US Market 11/15/2023

Opinion: How Biotechs Can Prepare for the Next Decade by Rethinking Conventional Business Models 11/15/2023

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of subcutaneous (SC, or under the skin) Tecentriq® (atezolizumab). Tecentriq SC can be injected in approximately seven minutes, with most injections taking between four and eight minutes compared with 30-60 minutes for intravenous (IV) infusion, which can free up time for patients, healthcare teams and caregivers.

Jazz Inks $770M Deal with GSK Spinout Autifony, Nabs Two Neuro Assets 11/14/2023